Luliact Lotion contains Luliconazole 1% w/v, a topical antifungal agent indicated for the treatment of superficial fungal infections of the skin, including dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole belongs to the imidazole class of antifungals and exhibits broad-spectrum activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane integrity and leading to fungal cell death. Luliact Lotion is formulated for once-daily application, providing effective management of fungal infections with improved patient compliance. It is suitable for use on affected areas such as the body, feet, and groin. Clinical studies have demonstrated that Luliconazole has superior efficacy and a favorable safety profile compared to other topical antifungals, with minimal adverse effects reported, primarily limited to mild local irritation or itching. The lotion base ensures good skin penetration and ease of application without leaving a greasy residue. Luliact Lotion should be used as directed by a healthcare professional, typically for a duration of two to four weeks depending on the infection type and severity. Patients are advised to avoid contact with eyes and mucous membranes and discontinue use if hypersensitivity reactions occur.